UNDERSTANDING THE BEHAVIOR OF PONOROGO COMMUNITY IN RECEIVING COVID-19 VACCINATION: A HEALTH BELIEF MODEL PERSPECTIVE

Authors

DOI:

https://doi.org/10.24269/ijhs.v9i2.11333

Abstract

Community behavior in accepting the COVID-19 vaccination still contains a lot of controversy. Negative news causes differences in the community's perception and response to behavior. This study aims to analyze the perception and behavior of the community in receiving the COVID-19 vaccination with the health model theory approach. The design of this study is cross-sectional, with the population of the Banaran Village, Pulung District, Ponorogo Regency, a total of 2,220 people. The number of respondents in this study was 100 people chosen by purposive sampling techniques. Research instruments using a questionnaire. In addition, data were analyzed using the Chi-Squared test. The results showed the relationship between the perception and behavior of the people receiving the COVID-19 vaccination, with a value of 0,000 <0.05. Increasing public perception and behaviors, the importance of COVID-19 vaccination can be applied using the theory of health belief models. The role of health workers is vital in educating the public about the significance of COVID-19 vaccination in suppressing transmission, severity, to death from COVID-19.

Author Biographies

Lina Ema Purwanti, Universitas Muhammadiyah Ponorogo

Nursing Department

Ririn Nasriati, Universitas Muhammadiyah Ponorogo

Nursing department

References

[1] A. Gori, F. Fama, and C. Genovese, “Coronavirus Disease 19 (COVID-19),” in Sustainable Development Goals Series, vol. Part F2781, no. 4, 2023, pp. 137–142. doi: 10.1007/978-3-031-33851-9_21.
[2] M. Peng, “Outbreak of COVID-19: An emerging global pandemic threat.,” Biomed. Pharmacother., vol. 129, no. April, p. 110499, Sep. 2020, doi: 10.1016/j.biopha.2020.110499.
[3] R. K. Sinuraya, R. F. Nuwarda, M. J. Postma, and A. A. Suwantika, “Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia,” Global. Health, vol. 20, no. 1, p. 11, Feb. 2024, doi: 10.1186/s12992-023-00987-w.
[4] E. Mathie et al., “Explore the global data on COVID-19 vaccinations,” Our World in Data, 2023. https://ourworldindata.org/covid-vaccinations#explore-the-global-data-on-covid-19-vaccinations
[5] R. Tanoto, “COVID-19 vaccination post introduction evaluation (cPIE) in Indonesia,” WHO, 2023. https://www.who.int/indonesia/news/detail/05-07-2023-covid-19-vaccination-post-introduction-evaluation-(cpie)-in-indonesia
[6] P. (Perry) Li, “Annual Report 2022,” AIMS Energy, vol. 11, no. 1, pp. 135–139, 2023, doi: 10.3934/energy.2023007.
[7] I. Skafle, A. Nordahl-Hansen, D. S. Quintana, R. Wynn, and E. Gabarron, “Misinformation About COVID-19 Vaccines on Social Media: Rapid Review,” J. Med. Internet Res., vol. 24, no. 8, p. e37367, Aug. 2022, doi: 10.2196/37367.
[8] R. A. Dewi, J. H. Sutawardana, and A. Nistiandani, “Perception of COVID-19 Vaccination Based on Health Belief Model and the Acceptance of COVID-19 Booster Vaccination,” Nurse Media J. Nurs., vol. 13, no. 1, pp. 121–131, Apr. 2023, doi: 10.14710/nmjn.v13i1.47694.
[9] I. Hidayana, S. Amir, D. C. Pelupessy, and Z. Rahvenia, “Using a health belief model to assess COVID-19 vaccine intention and hesitancy in Jakarta, Indonesia,” PLOS Glob. Public Heal., vol. 2, no. 10, p. e0000934, Oct. 2022, doi: 10.1371/journal.pgph.0000934.
[10] A. R. Mohi, I. Y. Kusuma, M. N. Massi, and M. A. Bahar, “Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study,” Narra J, vol. 4, no. 2, p. e858, Jul. 2024, doi: 10.52225/narra.v4i2.858.
[11] D. I. Putri, A. Sriatmi, Desyana Indira Putri, Budiyono, and Ayun Sriatmi, “Public Perception of the COVID-19 Vaccine: Literature Review,” Media Publ. Promosi Kesehat. Indones., vol. 7, no. 7, pp. 1788–1796, Jul. 2024, doi: 10.56338/mppki.v7i7.5490.
[12] T. Lidia, A. Widayati, and P. E. Nirmala Dewi, “Health Belief Model for Public Acceptance of Implementing COVID-19 Vaccination in Singkawang City, Indonesia,” New Emirates Med. J., vol. 5, Feb. 2024, doi: 10.2174/0102506882279402231223055256.
[13] M. I. Nurmansyah et al., “Challenges of COVID‐19 vaccination program in rural areas of Eastern Indonesia: A qualitative study from a multistakeholder perspective,” World Med. Heal. Policy, vol. 16, no. 2, pp. 134–152, Jun. 2024, doi: 10.1002/wmh3.592.
[14] G. A. Yudarwati, I. A. Putranto, I. N. Ratriyana, and P. Parera, “Towards an Interactive and Participatory Risk Communication: Lessons Learned from COVID-19 in Indonesia,” Cogent Soc. Sci., vol. 9, no. 1, Dec. 2023, doi: 10.1080/23311886.2023.2221594.
[15] F. Efendi et al., “Policies and cultural beliefs: Community perceptions about COVID‐19 vaccine hesitancy in Indonesia,” Public Health Nurs., vol. 41, no. 4, pp. 736–744, Jul. 2024, doi: 10.1111/phn.13318.
[16] Y. Lama, A. Budenz, A. Gaysynsky, I. A. Iles, and W.-Y. Sylvia Chou, “Factors Associated With COVID-19 Behavioral Intentions: Findings From an Online Survey,” Am. J. Heal. Promot., vol. 36, no. 7, pp. 1183–1192, 2022, doi: 10.1177/08901171221093036.
[17] S. Al-Dahir et al., “COVID-19 Testing Behavior as a Predictor of COVID-19 Vaccination in Southeastern Louisiana: A Longitudinal Cohort Study,” Vaccines, vol. 12, no. 12, 2024, doi: 10.3390/vaccines12121338.
[18] G. Capurro, R. Maier, J. Tustin, C. G. Jardine, and S. Michelle Driedger, “‘They’re trying to bribe you and taking away your freedoms’: COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates,” Vaccine, vol. 40, no. 50, pp. 7280–7287, 2022, doi: 10.1016/j.vaccine.2022.10.058.
[19] J. O. Chilongola, K. M. Rwegoshola, O. H. Balingumu, H. S. Semvua, and E. T. Kwigizile, “COVID-19 Knowledge, Attitudes, Practices, and vaccination hesitancy in Moshi, Kilimanjaro Region, Northern Tanzania,” Tanzan. J. Health Res., vol. 23, no. 1, 2022, doi: 10.4314/thrb.v23i1.3.
[20] Y. Kim, R. Iachan, J. Boyle, and Y. Deng, “Association Between County-Level Social Vulnerability and Vaccine-Related Attitudes and Hesitancy Toward COVID-19 Vaccination in the United States,” Vaccines, vol. 12, no. 12, 2024, doi: 10.3390/vaccines12121368.
[21] R. K. Oladapo et al., “COVID-19 vaccination in low and middle-income countries: Creating a sustainable roadmap for promoting public health intervention,” Int. J. Health Plann. Manage., vol. 39, no. 5, pp. 1612–1625, 2024, doi: 10.1002/hpm.3834.
[22] P. Lun et al., “A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review,” PLoS One, vol. 17, no. 10 October, 2022, doi: 10.1371/journal.pone.0272642.
[23] M. M. Patwary et al., “Determinants of covid-19 vaccine acceptance among the adult population of bangladesh using the health belief model and the theory of planned behavior model,” Vaccines, vol. 9, no. 12, 2021, doi: 10.3390/vaccines9121393.
[24] J. Peng et al., “High likelihood of accepting COVID-19 Vaccine in a Latinx community at high SARS-CoV-2 risk in San Francisco,” Open Forum Infect. Dis., vol. 8, no. 10, 2021, doi: 10.1093/ofid/ofab202.
[25] K. Griva et al., “Evaluating rates and determinants of covid-19 vaccine hesitancy for adults and children in the singapore population: Strengthening our community’s resilience against threats from emerging infections (socrates) cohort,” Vaccines, vol. 9, no. 12, 2021, doi: 10.3390/vaccines9121415.
[26] I. Berrou et al., “Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme,” Vaccines, vol. 10, no. 6, 2022, doi: 10.3390/vaccines10060840.
[27] A. Mahafzah, M. Sallam, F. G. Bakri, and M. S. Mubarak, “The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region,” in Advances in Experimental Medicine and Biology, vol. 1457, Department of Pathology, Microbiology, and Forensic Medicine, School of Medicine, The University of Jordan, Amman, 11942, Jordan: Springer, 2024, pp. 299–322. doi: 10.1007/978-3-031-61939-7_17.
[28] A. P. Fiebelkorn et al., “The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021—December 2022,” Vaccine, vol. 42, 2024, doi: 10.1016/j.vaccine.2023.12.061.
[29] T. O’Rourke and N. Iammarino, “The COVID-19 Challenge Now Is Getting Into Heads, Arms Will Follow,” Am. J. Heal. Educ., vol. 52, no. 6, pp. 352–359, 2021, doi: 10.1080/19325037.2021.1973619.

Downloads

Published

2025-09-25

Issue

Section

Artikel